Frontiers in Pharmacology

22.5k papers and 389.9k indexed citations i.

About

The 22.5k papers published in Frontiers in Pharmacology in the last decades have received a total of 389.9k indexed citations. Papers published in Frontiers in Pharmacology usually cover Molecular Biology (8.6k papers), Oncology (2.5k papers) and Pharmacology (2.4k papers) specifically the topics of Pharmacological Effects of Natural Compounds (885 papers), Computational Drug Discovery Methods (657 papers) and Neuroscience and Neuropharmacology Research (646 papers). The most active scholars publishing in Frontiers in Pharmacology are Filippo Drago, Guibo Sun, Bey Hing Goh, Claudio Bucolo and Thomas Efferth.

In The Last Decade

Fields of papers published in Frontiers in Pharmacology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Frontiers in Pharmacology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Frontiers in Pharmacology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Frontiers in Pharmacology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Frontiers in Pharmacology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025